Overview of autologous stem cell transplantation.

[1]  M. Picón,et al.  Peripheral blood CD34+ cell immunomagnetic selection in breast cancer patients: effect on hematopoietic progenitor content and hematologic recovery after high‐dose chemotherapy and autotransplantation , 2008, Transfusion.

[2]  R. Gray,et al.  Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone , 1999, Cancer.

[3]  T. Klingebiel,et al.  Clinical scale isolation of highly purified peripheral CD34+progenitors for autologous and allogeneic transplantation in children , 1999, Bone Marrow Transplantation.

[4]  W. Bezwoda.  Randomised controlled trial of high dose chemotherapy (HD-CNVp) versus standard dose (CAF) chemotherapy for high risk, surgically treated, primary breast cancer , 1999 .

[5]  A. Gratwohl,et al.  Blood and marrow transplantation activity in Europe 1997 , 1999, Bone Marrow Transplantation.

[6]  R. Larson,et al.  Dose-intensive therapy for adult acute lymphoblastic leukemia. , 1999, Seminars in oncology.

[7]  F. Appelbaum,et al.  Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. , 1998, The New England journal of medicine.

[8]  Ph,et al.  Primordial role of CD34+38− cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantation , 1998, British journal of haematology.

[9]  J. Peterse,et al.  Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement , 1998, The Lancet.

[10]  N. Gorin.  Autologous stem cell transplantation in acute myelocytic leukemia. , 1998, Blood.

[11]  M. Labopin,et al.  Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation--results of a retrospective analysis on 120 patients autografted in a single institution. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  K. Sullivan,et al.  Association between pretransplant interferon-α and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase , 1998 .

[13]  R. Bataille,et al.  Prognostic factors for survival and response after high‐dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients , 1998, British journal of haematology.

[14]  T. Shea,et al.  Multiple cycles of high-dose chemotherapy for ovarian cancer. , 1998, Seminars in oncology.

[15]  T. Klingebiel,et al.  Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting , 1998, Bone Marrow Transplantation.

[16]  F. Mandelli,et al.  BCR-ABL Antisense Oligodeoxynucleotide In Vitro Purging and Autologous Bone Marrow Transplantation for Patients With Chronic Myelogenous Leukemia in Advanced Phase , 1998 .

[17]  N. Kröger,et al.  Purging and haemopoietic progenitor cell selection by CD34+ cell separation , 1998, Bone Marrow Transplantation.

[18]  W. Siegert,et al.  Germ cell tumors: dose-intensive therapy. , 1998, Seminars in oncology.

[19]  R. Bouabdallah,et al.  Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin’s disease: retrospective analysis of 158 cases from the French registry , 1998, Bone Marrow Transplantation.

[20]  A. Balas,et al.  Progenitor cell subsets and engraftment kinetics in children undergoing autologous peripheral blood stem cell transplantation , 1998, British journal of haematology.

[21]  Keith Wheatley,et al.  Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial , 1998, The Lancet.

[22]  Richard J. Jones,et al.  Acute bleeding after bone marrow transplantation (BMT)- incidence and effect on survival. A quantitative analysis in 1,402 patients. , 1998, Blood.

[23]  G. Blandino,et al.  Expression of exogenous wt-p53 does not affect normal hematopoiesis: implications for bone marrow purging , 1997, Gene Therapy.

[24]  A. Nademanee,et al.  Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk group. , 1997, Blood.

[25]  L. Verdonck,et al.  Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. , 1997, Blood.

[26]  S. Tura,et al.  Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies. , 1997, Experimental hematology.

[27]  L. Vahdat,et al.  High‐dose chemotherapy with autologous stem cell support for breast cancer , 1997, Current opinion in hematology.

[28]  K. Akashi,et al.  Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia , 1997, Bone Marrow Transplantation.

[29]  A. Gratwohl,et al.  Hemopoietic blood and marrow transplants in the treatment of severe autoimmune disease , 1997, Current opinion in hematology.

[30]  M. Labopin,et al.  Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). , 1997, Blood.

[31]  P. Hurteloup,et al.  Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM). , 1997, Blood.

[32]  S. Sallan,et al.  Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. , 1997, Blood.

[33]  P. Iversen,et al.  Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome. , 1997, Journal of hematotherapy.

[34]  G. Hortobagyi,et al.  Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  N. Schmitz,et al.  Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL , 1997, Bone Marrow Transplantation.

[36]  C. Sawyers,et al.  Transplantation of autologous peripheral blood progenitor cells procured after high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia in first remission , 1997, Leukemia.

[37]  K. Atkinson,et al.  Haemopoietic stem cell transplantation in Australia, 1992-95: a report from the Australian Bone Marrow Transplant Recipient Registry. , 1997, Australian and New Zealand journal of medicine.

[38]  I. Tannock,et al.  Chemotherapy dose escalation: case unproven. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  J. Garcia-conde,et al.  Autologous stem cell transplantation for poor prognosis Hodgkin’s disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative group , 1997, Bone Marrow Transplantation.

[40]  C. Carlo-Stella,et al.  Stem cell manipulation: why and how performing peripheral blood progenitor cell purging. , 1997, Critical reviews in oncology/hematology.

[41]  M. Dyer,et al.  In vivo‘Purging’ of residual disease in CLL with Campath‐1H , 1997, British journal of haematology.

[42]  J. Serody,et al.  Prevention of infections in bone marrow transplant recipients. , 1997, Infectious disease clinics of North America.

[43]  A. Luini,et al.  Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  S. Forman,et al.  Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells , 1997, Leukemia.

[45]  A. Pileri,et al.  High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. , 1997, The New England journal of medicine.

[46]  J. Armitage,et al.  High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  B. Andersson,et al.  Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft‐versus‐host disease , 1997, British journal of haematology.

[48]  L. To,et al.  The biology and clinical uses of blood stem cells. , 1997, Blood.

[49]  R. Collins.  Autologous haemopoietic stem cell transplantation , 1997, The Lancet.

[50]  D. Dorsky,et al.  Stomatococcus mucilaginosus meningitis in a patient with multiple myeloma following autologous stem cell transplantation , 1997, Bone Marrow Transplantation.

[51]  P. Gaulard,et al.  Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  A. Goldstone,et al.  Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow T , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  S. Horning,et al.  Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. , 1997, Blood.

[54]  B. Barlogie,et al.  Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. , 1997, Blood.

[55]  D. Postic,et al.  Leptospirosis presenting as haemorrhagic fever in visitor to Africa , 1997, The Lancet.

[56]  D. Kohn.  Gene therapy for hematopoietic and immune disorders. , 1996, Bone marrow transplantation.

[57]  J. Dummer,et al.  Nocardial infections in bone marrow transplant recipients. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  N. Schmitz,et al.  Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. , 1996, Blood.

[59]  J. Gribben,et al.  High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. , 1996, Blood.

[60]  R. Champlin,et al.  Purging: the separation of normal from malignant cells for autologous transplantation , 1996, Transfusion.

[61]  A Kramar,et al.  High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  R. Falk,et al.  Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. , 1996, Blood.

[63]  É. Lepage,et al.  Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients , 1996, Cancer.

[64]  P. Colombat,et al.  Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  E. Shpall,et al.  Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. , 1996, Kidney international.

[66]  B. Barlogie,et al.  Autotransplants in multiple myeloma: what have we learned? , 1996, Blood.

[67]  M. Goormastic,et al.  Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. , 1996, Bone marrow transplantation.

[68]  J. Niland,et al.  In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  S. Kvaløy,et al.  Purging of tumor cells from leukapheresis products: experimental and clinical aspects. , 1996, Journal of hematotherapy.

[70]  E. Shpall,et al.  Use of amifostine in bone marrow purging. , 1996, Seminars in oncology.

[71]  S. Rodenhuis,et al.  The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis. , 1996, European journal of cancer.

[72]  J. Rossi,et al.  A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma , 1996 .

[73]  R. Storb,et al.  High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells. , 1996, Bone marrow transplantation.

[74]  M. Labopin,et al.  Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT). , 1996, Bone marrow transplantation.

[75]  A. Vekhoff,et al.  Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial , 1996 .

[76]  R. Storb,et al.  High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[77]  H. Klingemann,et al.  A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood. , 1996, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[78]  M. Horowitz,et al.  Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant Registry. , 1996, Bone marrow transplantation.

[79]  R. Motzer,et al.  High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  L. Grochow,et al.  Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[81]  W. Levy,et al.  Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. , 1996, Blood.

[82]  J. Vose,et al.  Cardiopulmonary function and autologous bone marrow transplantation: results and predictive value for respiratory failure and mortality. The University of Nebraska Medical Center Bone Marrow Transplantation Pulmonary Study Group. , 1996, Bone marrow transplantation.

[83]  R. Falk,et al.  Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. , 1996, The American journal of medicine.

[84]  F. Leeuwen.  4 Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment , 1996 .

[85]  F. Gherlinzoni,et al.  Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia. , 1996, Leukemia.

[86]  R. Tsang,et al.  The Role of Intensive Therapy and Autologous Blood and Marrow Transplantation for Chemotherapy‐Sensitive Relapsed and Primary Refractory Non‐Hodgkin’s Lymphoma: Identification of Major Prognostic Groups , 1996, British journal of haematology.

[87]  A. Gratwohl,et al.  Hematopoietic precursor cell transplants in Europe: activity in 1994. Report from the European Group for Blood and Marrow Transplantation (EBMT). , 1996, Bone marrow transplantation.

[88]  E. Ball,et al.  A combination of CD34 selection and complement-mediated immunopurging (anti-CD15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells. , 1996, Journal of hematotherapy.

[89]  M. Kajiwara,et al.  Usefulness of Lymphokine‐activated Killer Cells Generated from Bone Marrow Mononuclear Cells for the Purging of Residual Tumor Cells in Peripheral Blood Stem Cell Graft , 1996, Japanese journal of cancer research : Gann.

[90]  M. Subar.  Risk stratification for high-dose chemotherapy in metastatic breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  A. Hagenbeek,et al.  Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. , 1995, The New England journal of medicine.

[92]  R. Scimé,et al.  CD34+ cell subsets and platelet recovery after PBSC autograft. , 1995, Bone marrow transplantation.

[93]  H. Heslop,et al.  Gene transfer for the therapy of hematologic malignancy , 1995, Current opinion in hematology.

[94]  J. Thomson,et al.  Transmission of thyrotoxicosis of autoimmune type by sibling allogeneic bone marrow transplant. , 1995, European journal of endocrinology.

[95]  L. Seymour,et al.  High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[96]  Van Bekkum Dw,et al.  Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain , 1995 .

[97]  D. Blaise,et al.  Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group. , 1995, Blood.

[98]  S. Heimfeld,et al.  Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. , 1995, The New England journal of medicine.

[99]  D. Fairclough,et al.  Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[100]  D. Reece,et al.  High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy. , 1995, Blood.

[101]  L. Silberstein,et al.  Peripheral blood progenitor cell generation and harvesting. , 1995, Seminars in oncology.

[102]  A. Nienhuis,et al.  Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. , 1995, Blood.

[103]  J. Bourhis,et al.  Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma. , 1995, Stem cells.

[104]  B. Andersson,et al.  Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[105]  J. Raemaekers,et al.  Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. , 1995, The New England journal of medicine.

[106]  P. Bierman,et al.  Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[107]  H. Lazarus,et al.  Bone marrow transplantation in low-grade non-Hodgkin's lymphoma. , 1995, Leukemia & lymphoma.

[108]  C. Carlo-Stella,et al.  Stem cell purging: an intriguing dilemma. , 1995, Experimental hematology.

[109]  L. Fouillard,et al.  Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. , 1995, Blood.

[110]  H. Kantarjian,et al.  Collection of peripheral-blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[111]  E. Copelan,et al.  The biology and treatment of acute lymphoblastic leukemia in adults. , 1995, Blood.

[112]  B. Barraclough,et al.  Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[113]  F. Mandelli,et al.  Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. , 1995, The New England journal of medicine.

[114]  R. Hoppe,et al.  Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[115]  W. Chan,et al.  Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[116]  G. Meloni,et al.  Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT. , 1994, Bone marrow transplantation.

[117]  R. Bouabdallah,et al.  Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission. , 1994, Bone marrow transplantation.

[118]  S. Goff,et al.  Transfer and expression of the human multiple drug resistance gene in human CD34+ cells. , 1994, Blood.

[119]  J. Crowley,et al.  High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants , 1994 .

[120]  A. Deisseroth,et al.  Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups , 1994, The Lancet.

[121]  S. Heimfeld,et al.  Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. , 1994, Blood.

[122]  A. Goldstone,et al.  Germ cell failure and Leydig cell insufficiency in post-pubertal males after autologous bone marrow transplantation with BEAM for lymphoma. , 1994, Bone marrow transplantation.

[123]  G. Hortobagyi,et al.  Factors predicting long‐term survival for metastatic breast cancer patients treated with high‐dose chemotherapy and bone marrow support , 1994, Cancer.

[124]  M. Gore,et al.  High-dose melphalan for multiple myeloma: long-term follow-up data. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[125]  M. Boccadoro,et al.  High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[126]  G. Leone,et al.  Haemopoietic reconstitution after autologous blood stem cell transplantation in patients with malignancies: a multicentre retrospective study , 1994, British journal of haematology.

[127]  R. Gray,et al.  Autografting for patients with CML in chronic phase: an update , 1994, British journal of haematology.

[128]  S. Crawford,et al.  Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[129]  J. Armitage,et al.  High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[130]  P. Ravaud,et al.  High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. , 1993, Blood.

[131]  G. Gahrton,et al.  Intensive treatment in order to minimize the ph‐positive clone in chronic myelogenic leukemia , 1993, Stem cells.

[132]  Emili Montserrat,et al.  A predictive model for aggressive non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.

[133]  D. Neuberg,et al.  Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. , 1993, Blood.

[134]  W. Wilson,et al.  EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[135]  A. Ben-nun,et al.  Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation. , 1993, The Journal of clinical investigation.

[136]  F. Appelbaum,et al.  Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[137]  G. Rosner,et al.  High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[138]  J. Lipton,et al.  Pregnancy after BMT: three case reports. , 1993, Bone marrow transplantation.

[139]  D. Winfield,et al.  Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial , 1993, The Lancet.

[140]  C. Hillyer,et al.  CD34+ progenitors and colony‐forming units‐granulocyte macrophage are recruited during large‐volume leukapheresis and concentrated by counterflow centrifugal elutriation , 1993, Transfusion.

[141]  M. Crump,et al.  High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[142]  D. Colquhoun,et al.  Three case reports , 1993, The Medical journal of Australia.

[143]  D. V. van Bekkum,et al.  Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. , 1993, Bone marrow transplantation.

[144]  S. Ikehara,et al.  Prevention of autoimmune inflammatory polyarthritis in male New Zealand black/KN mice by transplantation of bone marrow cells plus bone (stromal cells). , 1993, Arthritis and rheumatism.

[145]  W. Anderson,et al.  Gene-marking to trace origin of relapse after autologous bone-marrow transplantation , 1993, The Lancet.

[146]  K. Propert,et al.  Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. , 1992, The New England journal of medicine.

[147]  C. Eaves,et al.  Characterization of primitive hematopoietic cells in normal human peripheral blood. , 1992, Blood.

[148]  M. Labopin,et al.  Autologous bone marrow transplantation in 2502 patients with acute leukemia in Europe: a retrospective study. , 1992, Leukemia.

[149]  B. Barlogie,et al.  Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. , 1992, Blood.

[150]  W. Willett,et al.  Breast cancer (2). , 1992, The New England journal of medicine.

[151]  G. Tricot,et al.  Long-Term Outcome of Patients with Relapsed and Refractory Germ Cell Tumors Treated with High-Dose Chemotherapy and Autologous Bone Marrow Rescue , 1992, Annals of Internal Medicine.

[152]  I. Pastan,et al.  Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. , 1992, Science.

[153]  A. Freedman,et al.  Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. , 1992, Journal of Clinical Oncology.

[154]  R. Motzer,et al.  Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[155]  N. Ifrah,et al.  Double-intensive therapy in high-risk multiple myeloma. , 1992, Blood.

[156]  J. Lebkowski,et al.  RAPID ISOLATION OF HUMAN CD34 HEMATOPOIETIC STEM CELLS—PURGING OF HUMAN TUMOR CELLS , 1992, Transplantation.

[157]  L. To,et al.  Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. , 1992, Bone marrow transplantation.

[158]  G. Kandel,et al.  Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. , 1992, Bone marrow transplantation.

[159]  B. Barlogie,et al.  Autologous bone marrow transplantation for multiple myeloma. , 1992, Hematology/oncology clinics of North America.

[160]  D. Trump,et al.  High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[161]  R. M. Fox,et al.  Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy , 1992, The Lancet.

[162]  D. Longo,et al.  Hodgkin's disease. , 1992, The New England journal of medicine.

[163]  B. Mazières,et al.  Intensive combined therapy for previously untreated aggressive myeloma. , 1992, Blood.

[164]  C. Verfaillie,et al.  Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. , 1992, Blood.

[165]  E. Jaffe,et al.  Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[166]  D. Weisenburger,et al.  Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease. , 1991, The American journal of medicine.

[167]  J. Gribben,et al.  Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. , 1991, The New England journal of medicine.

[168]  D. V. van Bekkum,et al.  Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. , 1991, Bone marrow transplantation.

[169]  G. Scambia,et al.  Autologous blood stem cell harvesting and transplantation in patients with advanced ovarian cancer , 1991, British journal of haematology.

[170]  C. Bokemeyer,et al.  Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[171]  C. Théodore,et al.  Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancer. , 1991, European journal of cancer.

[172]  F. Appelbaum,et al.  Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[173]  P. Cony-Makhoul,et al.  Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: a report of 47 cases , 1991, British journal of haematology.

[174]  D. Deakin,et al.  Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. , 1991, The Quarterly journal of medicine.

[175]  A. Goldstone,et al.  Autologous bone marrow transplantation for non‐Hodgkin's lymphoma , 1991, European journal of haematology.

[176]  J. Armitage,et al.  Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[177]  E. Dmitrovsky,et al.  The role of ifosfamide plus cisplatin‐based chemotherapy as salvage therapy for patients with refractory germ cell tumors , 1990, Cancer.

[178]  L. To,et al.  Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. , 1990, Experimental hematology.

[179]  G. Meloni,et al.  Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. , 1990, Blood.

[180]  P. Colombat,et al.  The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[181]  S. Piantadosi,et al.  High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[182]  P. Sonneveld,et al.  Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[183]  A. Pileri,et al.  GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION , 1989, The Lancet.

[184]  R. Marcus,et al.  Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis , 1989, British journal of haematology.

[185]  G. Tricot,et al.  Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[186]  N. Nissen,et al.  Follicular low‐grade non‐Hodgkin's lymphoma: Long‐term outcome with or without tumor progression , 1989, European journal of haematology.

[187]  J. Armitage,et al.  Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[188]  C. Bloomfield,et al.  The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas. , 1988, Annals of internal medicine.

[189]  B. Barlogie,et al.  Prognostic factors with high-dose melphalan for refractory multiple myeloma [see comments] , 1988 .

[190]  A. Carella,et al.  Autologous unpurged bone marrow transplantation for acute non-lymphoblastic leukaemia in first complete remission. , 1988, Bone marrow transplantation.

[191]  L. Einhorn,et al.  Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide. , 1988, Annals of internal medicine.

[192]  P. Biron,et al.  High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[193]  K. Sullivan,et al.  Ovarian function following marrow transplantation for aplastic anemia or leukemia. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[194]  D. Williams,et al.  Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow , 1987, The Journal of experimental medicine.

[195]  J. Armitage,et al.  High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. , 1987, The New England journal of medicine.

[196]  S. Rosenberg.  Autologous bone marrow transplantation in non-Hodgkin's lymphoma. , 1987, The New England journal of medicine.

[197]  W. Velasquez,et al.  Results of MIME salvage regimen for recurrent or refractory lymphoma. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[198]  D. Linch,et al.  Autologous bone marrow transplantation following high dose chemotherapy for the treatment of adult patients with acute myeloid leukaemia , 1986, British journal of haematology.

[199]  T. Lister,et al.  Follicular lymphoma: prognostic factors for response and survival. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[200]  R. Storb,et al.  Autologous marrow transplantation in patients with acute nonlymphocytic leukemia in first remission. , 1985, Experimental hematology.

[201]  J. Cairncross,et al.  Complications of Chemotherapy , 1985, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[202]  W. Haseltine,et al.  Alkylating agent resistance: in vitro studies with human cell lines. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[203]  L. Mangoni,et al.  In vitro restoration of polyclonal hematopoiesis in a chronic myelogenous leukemia after in vitro treatment with 4-hydroperoxycyclophosphamide. , 1985, Blood.

[204]  S. Horning,et al.  The natural history of initially untreated low-grade non-Hodgkin's lymphomas. , 1984, The New England journal of medicine.

[205]  N. Wareham,et al.  Chemotherapy and autografting for chronic granulocytic leukaemia in transformation: probable prolongation of survival for some patients , 1984, British journal of haematology.

[206]  A. Burnett,et al.  TRANSPLANTATION OF UNPURGED AUTOLOGOUS BONE-MARROW IN ACUTE MYELOID LEUKAEMIA IN FIRST REMISSION , 1984, The Lancet.

[207]  T. Mcelwain,et al.  HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMA , 1983, The Lancet.

[208]  A. Pestronk,et al.  Combined short‐term immunotherapy for experimental autoimmune myasthenia gravis , 1983, Annals of neurology.

[209]  L. Coulombel,et al.  Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. , 1983, The New England journal of medicine.

[210]  S. Sharkis,et al.  Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide. , 1980, Blood.

[211]  R. Storb,et al.  Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation. , 1977, Blood.

[212]  R. Storb,et al.  Bone marrow transplantation in patients with gold-induced marrow aplasia. , 1977, Arthritis and rheumatism.

[213]  D. Waber,et al.  AMITRIPTYLINE THERAPY IN PATIENTS WITH ANOREXIA NERVOSA , 1976, The Lancet.

[214]  Z. Fuks,et al.  Non‐hodgkin's lymphomas iv. clinicopathologic correlation in 405 cases , 1973, Cancer.

[215]  D. Boggs,et al.  In vitro growth of granulocytic and mononuclear cell colonies from blood of normal individuals. , 1971, Blood.

[216]  E. Hersh,et al.  Cells Capable of Colony Formation in the Peripheral Blood of Man , 1971, Science.

[217]  D. Smithers.  Hodgkin's disease. II. , 1967, British medical journal.

[218]  J. Bryant,et al.  Allogeneic marrow engraftment by cross circulation in lethally irradiated dogs. , 1966, Blood.

[219]  G. Hortobagyi,et al.  Registry results and high-dose therapy. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[220]  C. Solano,et al.  Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry , 1998, Bone Marrow Transplantation.

[221]  J. Vose.  High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphoma. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[222]  J. Gribben,et al.  High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[223]  R. Bouabdallah,et al.  Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution. , 1998, Leukemia & lymphoma.

[224]  B. Coiffier.  Which treatment for mantle-cell lymphoma patients in 1998? , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[225]  D. Berry,et al.  Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver , 1998, Bone Marrow Transplantation.

[226]  H. Lazarus.  Hematopoietic progenitor cell transplantation in breast cancer: current status and future directions. , 1998, Cancer investigation.

[227]  F. Montemurro,et al.  [Prevention and treatment of febrile neutropenia]. , 1997, Tumori.

[228]  B. Barlogie,et al.  Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation. , 1997, Leukemia & lymphoma.

[229]  D. Huhn,et al.  Long term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy , 1997, Cancer.

[230]  J. Apperley,et al.  Paranasal sinusitis following allogeneic bone marrow transplant , 1997, Bone Marrow Transplantation.

[231]  E. Ball,et al.  Purging marrow or peripheral blood stem cells for autografting , 1997, Current opinion in hematology.

[232]  W. Koo,et al.  Role of maintenance oral dexamethasone in prophylaxis of delayed emesis caused by moderately emetogenic chemotherapy. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[233]  K. Meehan,et al.  Stem cell transplantation with chemoradiotherapy myeloablation and interleukin-2. , 1996, The Journal of infusional chemotherapy.

[234]  P. Goss,et al.  Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodes. , 1996, Journal of Clinical Oncology.

[235]  A. Goldstone,et al.  Gonadal damage and effects on fertility in adult patients with haematological malignancy undergoing stem cell transplantation. , 1996, Bone marrow transplantation.

[236]  N. Gorin.  The potential role of amifostine (Ethyol) in haematological malignancies. , 1996, European journal of cancer.

[237]  R. Krance,et al.  Use of gene marking in bone marrow transplantation. , 1996, Cancer detection and prevention.

[238]  P. Ljungman,et al.  [Infections following bone marrow transplantation]. , 1995, Nordisk medicin.

[239]  D. Weisdorf,et al.  Autologous stem cell transplantation for refractory and relapsed Hodgkin's disease: factors predictive of prolonged survival. , 1995, Bone marrow transplantation.

[240]  A. Goldstone,et al.  Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: a case-controlled analysis of the EBMT Registry data. Lymphoma Working Party of the EBMT. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[241]  E. Shpall,et al.  Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[242]  K Kato,et al.  Isolation and characterization of CD34+ hematopoietic stem cells from human peripheral blood by high-gradient magnetic cell sorting. , 1993, Cytometry.

[243]  J. Biggs,et al.  Apparent cure of rheumatoid arthritis by bone marrow transplantation. , 1993, The Journal of rheumatology.

[244]  A. Keating,et al.  The CD34 antigen: structure, biology, and potential clinical applications. , 1992, Journal of hematotherapy.

[245]  J. Yin,et al.  Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. , 1992, Bone marrow transplantation.

[246]  G. Tricot,et al.  High dose carboplatin/VP-16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors. , 1991, Bone marrow transplantation.

[247]  M. Labopin,et al.  Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe : further evidence of the role of marrow purging by mafosfamide , 1991 .

[248]  A. Keating,et al.  Human long-term bone marrow culture. , 1990, Methods in molecular biology.

[249]  B. Bostrom,et al.  Treatment of refractory and relapsed Hodgkin's disease: intensive chemotherapy and autologous bone marrow or peripheral blood stem cell support. , 1990, Medical and pediatric oncology.

[250]  R. Storb,et al.  Growth and development after bone marrow transplantation. , 1989, Progress in clinical and biological research.

[251]  B. Teicher,et al.  Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo. , 1988, Cancer research.

[252]  S. Jagannath,et al.  Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). , 1988, Blood.

[253]  G. Galloway,et al.  Malignant Hyper-Pyrexia and Sudden Infant Death , 1982 .

[254]  R. Storb,et al.  Successful pregnancy after high dose chemotherapy and marrow transplantation for treatment of aplastic anemia. , 1980, Experimental hematology.